Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Not yet recruiting 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 4Lymphoid 3Tumor-Agnostic 1Thoracic 1Sarcoma 1Plasma cell 1Endocrine 1

Conditions

Neurotoxicity Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Hodgkin Disease 1Cytokine Release Syndrome 1

Interventions

Cyclophosphamide 47Rituximab 34Exercise 25fludarabine phosphate 24Methotrexate 24Blood Specimen Collection 23Vincristine 21Cytarabine 21Radiotherapy 20Filgrastim 19Peripheral Blood Stem Cell Transplantation 18Whole-Body Irradiation 17Prednisone 16Melphalan 16Etoposide 16Cyclosporine 16Methods 15Dexamethasone 15Busulfan 15Antilymphocyte Serum 15fludarabine 14Doxorubicin 14Educational Status 13Mycophenolic Acid 12Magnetic Resonance Spectroscopy 11Early Intervention, Educational 11Therapeutics 10Surveys and Questionnaires 9Standard of Care 9Prednisolone 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Neuropsychological Tests × Lymphoid × Clear all
NCT05416554 2025-02-11

Long-term Cognitive, Neuropsychiatric and Functional Outcomes in Adults Who Have Received Chimeric Antigen-Receptor T-Cell (CAR-T) Therapy for Aggressive Lymphoma at Stanford

Stanford University

Phase NA Not yet recruiting
20 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT05510596 2024-08-09

MR-ICANS

University Hospital, Montpellier

Phase NA Completed
25 enrolled
Lymphoid

Cytokine Release Syndrome, Lymphoma, B-Cell, Neurotoxicity Syndromes

NCT06116929 2024-02-28

FunC-AHOD

Lille Catholic University

Phase NA Not yet recruiting
63 enrolled
Lymphoid

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡